ES373199A1 - Procedimiento para producir un compuesto de prostaglandina. - Google Patents
Procedimiento para producir un compuesto de prostaglandina.Info
- Publication number
- ES373199A1 ES373199A1 ES373199A ES373199A ES373199A1 ES 373199 A1 ES373199 A1 ES 373199A1 ES 373199 A ES373199 A ES 373199A ES 373199 A ES373199 A ES 373199A ES 373199 A1 ES373199 A1 ES 373199A1
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- alkanoyl
- cis
- formul
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229940006138 antiglaucoma drug and miotics prostaglandin analogues Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000133 nasal decongestant Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77513168A | 1968-11-12 | 1968-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES373199A1 true ES373199A1 (es) | 1972-03-16 |
Family
ID=25103422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES373199A Expired ES373199A1 (es) | 1968-11-12 | 1969-11-05 | Procedimiento para producir un compuesto de prostaglandina. |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE741555A (pt) |
| BR (1) | BR6913826D0 (pt) |
| CH (2) | CH540215A (pt) |
| DE (1) | DE1956290A1 (pt) |
| DK (1) | DK134507B (pt) |
| ES (1) | ES373199A1 (pt) |
| FR (1) | FR2024837B1 (pt) |
| GB (1) | GB1251750A (pt) |
| IL (1) | IL33226A (pt) |
| NL (1) | NL6916822A (pt) |
| PL (1) | PL80526B1 (pt) |
| SE (1) | SE380015B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0200258A2 (hu) | 1999-03-05 | 2002-05-29 | The Procter & Gamble Co. | C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290226A (en) * | 1964-02-19 | 1966-12-06 | Upjohn Co | Microbiological conversion of unsaturated fatty acids |
| US3505386A (en) * | 1965-12-29 | 1970-04-07 | Upjohn Co | Compounds related to prostaglandins |
| GB1198071A (en) * | 1966-08-09 | 1970-07-08 | George Erich Just | Improvements in or relating to Prostaglandin Analogues and the Manufacture thereof |
| US3435053A (en) * | 1966-06-06 | 1969-03-25 | Upjohn Co | Cyclopenta(b)pyrans |
-
1969
- 1969-10-03 GB GB1251750D patent/GB1251750A/en not_active Expired
- 1969-10-21 IL IL33226A patent/IL33226A/en unknown
- 1969-10-27 CH CH1844371A patent/CH540215A/de not_active IP Right Cessation
- 1969-10-27 CH CH1605169A patent/CH517685A/de not_active IP Right Cessation
- 1969-10-31 BR BR213826/69A patent/BR6913826D0/pt unknown
- 1969-11-05 ES ES373199A patent/ES373199A1/es not_active Expired
- 1969-11-07 NL NL6916822A patent/NL6916822A/xx unknown
- 1969-11-08 DE DE19691956290 patent/DE1956290A1/de active Pending
- 1969-11-11 SE SE6915475A patent/SE380015B/xx unknown
- 1969-11-11 PL PL1969136834A patent/PL80526B1/pl unknown
- 1969-11-11 DK DK595469AA patent/DK134507B/da unknown
- 1969-11-12 BE BE741555D patent/BE741555A/xx unknown
- 1969-11-12 FR FR696938853A patent/FR2024837B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK134507C (pt) | 1977-04-18 |
| IL33226A (en) | 1973-10-25 |
| PL80526B1 (pt) | 1975-08-30 |
| BR6913826D0 (pt) | 1973-02-13 |
| DK134507B (da) | 1976-11-22 |
| NL6916822A (pt) | 1970-05-14 |
| DE1956290A1 (de) | 1970-06-11 |
| IL33226A0 (en) | 1969-12-31 |
| FR2024837A1 (pt) | 1970-09-04 |
| CH517685A (de) | 1972-01-15 |
| SE380015B (pt) | 1975-10-27 |
| GB1251750A (pt) | 1971-10-27 |
| FR2024837B1 (pt) | 1973-07-13 |
| BE741555A (pt) | 1970-05-12 |
| CH540215A (de) | 1973-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1160627A (en) | 9-deoxy-6,9-epoxyprostaglandins | |
| US4097489A (en) | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds | |
| US4127725A (en) | Cis-13-PGE1,15-methyl esters | |
| US4232009A (en) | ω-Halo-PGI2 analogues | |
| DE2753986A1 (de) | Prostaglandin e-artige derivate und analoga mit 6-ketofunktion und verfahren zu deren herstellung | |
| ES373199A1 (es) | Procedimiento para producir un compuesto de prostaglandina. | |
| US4098805A (en) | 9-deoxy-9-methylene-pgf-type amides | |
| US3767695A (en) | Prostaglandin e1, f1, and a1 analogs | |
| US4207332A (en) | Prostaglandin I2 analogues | |
| GB1355147A (en) | Oxoprostanoic acid derivatives | |
| CA1159452A (en) | (5e)-9-deoxy-6,9-epoxy-prostaglandin derivatives | |
| GB1285372A (en) | Improvements in or relating to prostaglandins and the preparation thereof | |
| CA1072549A (en) | Thiaprostaglandine | |
| GB1496491A (en) | Dihydroergopeptine derivatives | |
| US4118584A (en) | 9-Deoxy-9-methylene-16-phenyl-PGF compounds | |
| IE43465B1 (en) | 11-oxo-prostaglandin derivatives and process for their manufacture | |
| JPS6151597B2 (pt) | ||
| CH639378A5 (de) | Prostaglandin-derivate und verfahren zu deren herstellung. | |
| GB1529251A (en) | 9,10-dihydroergopeptines | |
| GB1316894A (en) | Benzimidazole derivatives | |
| GB1202010A (en) | Prostaglandins and the manufacture thereof | |
| US4130591A (en) | 2-Decarboxy-2-hydroxy-methyl-13,14-didehydro-16-phenoxy PGF compounds | |
| CH624100A5 (pt) | ||
| JPS5573678A (en) | Simultated compound of thio-prostaglandin i1, its preparation and drug composition containing it as active ingredient | |
| GB1183841A (en) | Prostaglandin Related Compounds |